Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Withdrawn × Androgen Antagonists × Clear all

Phase

Phase 2 3 Phase NA 1 Phase 1 1

Status

Recruiting 6 Unknown 3 Completed 3 Active not recruiting 3 Withdrawn 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 16 Radiosurgery 14 Exercise 13 Biopsy 10 Educational Status 8 Cyclophosphamide 8 Surveys and Questionnaires 6 Radiotherapy 6 Methods 6 Early Intervention, Educational 6 Doxorubicin 6 Cisplatin 6 Blood Specimen Collection 6 Therapeutics 5 Radiotherapy, Intensity-Modulated 5 Fluorodeoxyglucose F18 5 Cryosurgery 5 Colonoscopy 5 Water 4 Standard of Care 4 Irinotecan 4 Electroporation 4 Drug Therapy 4 alovudine 3 Yoga 3 X-Rays 3 Vincristine 3 Transplantation 3 Practice Guidelines as Topic 3 Polymerase Chain Reaction 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01811810 2019-04-23

Proton Therapy for High Risk Prostate Cancer

Abramson Cancer Center at Penn Medicine

Phase NA Withdrawn

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡